Boot AM - Search Results

1

Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.

Roke Y, van Harten PN, Boot AM, Buitelaar JK. Roke Y, et al. Among authors: boot am. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):403-14. doi: 10.1089/cap.2008.0120. J Child Adolesc Psychopharmacol. 2009. PMID: 19702492 Review.

2

Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment.

Roke Y, van Harten PN, Buitelaar JK, Tenback DE, Quekel LG, de Rijke YB, Boot AM. Roke Y, et al. Among authors: boot am. Eur J Endocrinol. 2012 Dec;167(6):855-63. doi: 10.1530/EJE-12-0521. Epub 2012 Sep 25. Eur J Endocrinol. 2012. PMID: 23011870

3

Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.

Mergler S, Evenhuis HM, Boot AM, De Man SA, Bindels-De Heus KG, Huijbers WA, Penning C. Mergler S, et al. Among authors: boot am. Dev Med Child Neurol. 2009 Oct;51(10):773-8. doi: 10.1111/j.1469-8749.2009.03384.x. Epub 2009 Jul 8. Dev Med Child Neurol. 2009. PMID: 19614941 Review.

4

The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.

Roke Y, van Harten PN, Franke B, Galesloot TE, Boot AM, Buitelaar JK. Roke Y, et al. Among authors: boot am. Pharmacogenet Genomics. 2013 Sep;23(9):487-93. doi: 10.1097/FPC.0b013e3283647c33. Pharmacogenet Genomics. 2013. PMID: 23851570

5

Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.

Roke Y, Buitelaar JK, Boot AM, Tenback D, van Harten PN. Roke Y, et al. Among authors: boot am. J Child Adolesc Psychopharmacol. 2012 Dec;22(6):432-9. doi: 10.1089/cap.2011.0109. J Child Adolesc Psychopharmacol. 2012. PMID: 23234586

6

Antipsychotic-induced hyperprolactinemia and testosterone levels in boys.

Roke Y, van Harten PN, Buitelaar JK, Tenback DE, de Rijke YB, Boot AM. Roke Y, et al. Among authors: boot am. Horm Res Paediatr. 2012;77(4):235-40. doi: 10.1159/000337910. Epub 2012 Apr 26. Horm Res Paediatr. 2012. PMID: 22538969

7

Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.

Boot AM, van der Sluis IM, Krenning EP, de Muinck Keizer-Schrama SM. Boot AM, et al. Horm Res. 2009;71(6):364-71. doi: 10.1159/000223422. Epub 2009 Jun 9. Horm Res. 2009. PMID: 19506395

8

Efficacy and Safety of Bisphosphonate Therapy in Children with Osteogenesis Imperfecta: A Systematic Review.

Rijks EB, Bongers BC, Vlemmix MJ, Boot AM, van Dijk AT, Sakkers RJ, van Brussel M. Rijks EB, et al. Among authors: boot am. Horm Res Paediatr. 2015;84(1):26-42. doi: 10.1159/000381713. Epub 2015 May 23. Horm Res Paediatr. 2015. PMID: 26021524 Review.

9

Influence of birth size and body composition on bone mineral density in early adulthood: the PROGRAM study.

Leunissen RW, Stijnen T, Boot AM, Hokken-Koelega AC. Leunissen RW, et al. Among authors: boot am. Clin Endocrinol (Oxf). 2008 Sep;69(3):386-92. doi: 10.1111/j.1365-2265.2008.03226.x. Epub 2008 Feb 18. Clin Endocrinol (Oxf). 2008. PMID: 18284639

10

Vitamin D in childhood and adolescence: an expert position statement.

Saggese G, Vierucci F, Boot AM, Czech-Kowalska J, Weber G, Camargo CA Jr, Mallet E, Fanos M, Shaw NJ, Holick MF. Saggese G, et al. Among authors: boot am. Eur J Pediatr. 2015 May;174(5):565-76. doi: 10.1007/s00431-015-2524-6. Epub 2015 Apr 2. Eur J Pediatr. 2015. PMID: 25833762 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results